January 27, 2010 (FinancialWire) — YesDTC Holdings, Inc. (OTCBB: YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, announces the company has successfully completed negotiations with BioElectronics, Corp. (OTC: BIEL) to begin distribution of the award-winning ActiPatch™ Therapy disposable drug-free anti-inflammatory device throughout Japan.

Under the terms of the arrangement, YesDTC will hold full television, direct-to-consumer and retail distribution rights to consumers within the world’s second largest economy. YesDTC plans to initially launch distribution through direct response television advertising and is currently formulating plans for retail launch. ActiPatch is currently categorized within Japan as a Class I medical device.

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television, Internet and retail marketing programs.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.